Groundbreaking advancements in MASH cirrhosis treatment are rapidly emerging.Discover how GLP-1 and FGF21 analogs are reshaping the landscape of liver disease management,offering renewed hope for those affected. Recent studies highlight the potential of these novel drug therapies to significantly improve outcomes and revolutionize patient care. This article dives deep into the science, exploring the mechanisms … Read more
Hollywood is paying tribute to Loretta Swit after news of her death was announced Friday. According to a police report, the M*A*S*H star died of suspected natural causes at her home in New York City, her publicist, Harlan Boll, announced. Swit appeared in all but 11 episodes of M*A*S*H during its 11-season run, earning two … Read more
Loretta Swit, who played Major Margaret “Hot Lips” Houlihan on seminal TV comedy “MASH,” died Friday at her home in New York City. She was 87. Her rep Harlan Boll said she died of natural causes. More from Variety For her work on “MASH” Swit was Emmy nominated for outstanding performance by a supporting actress … Read more
The use of glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) may benefit liver health by reducing liver fat, hindering fibrosis progression, and even resolving metabolic dysfunction–associated steatohepatitis (MASH), according to a review of the evidence. This narrative literature review, published in Expert Opinion on Investigational Drugs, sought to elaborate on the pleiotropic impact of GLP-1 … Read more
Excessive screen time is associated with an increased risk of liver steatosis in adolescents, according to findings from a recent study.1 Leveraging data from National Health and Nutrition Examination Surveys (NHANES) 2017-2018 participants 12–17 years of age, the study found ≥ 5 hours of self-reported screen time per day was linked to a greater risk of … Read more
Excessive screen time is associated with an increased risk of liver steatosis in adolescents, according to findings from a recent study.1 Leveraging data from National Health and Nutrition Examination Surveys (NHANES) 2017-2018 participants 12–17 years of age, the study found ≥ 5 hours of self-reported screen time per day was linked to a greater risk of … Read more
Vincent Chen, MD Credit: Michigan Medicine Cardiometabolic risk factors, physical activity, diet, and social determinants of health are associated with health-related quality of life (HRQoL) and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to findings from a recent study.1 The cross-sectional analysis included a prospectively enrolled cohort of patients with MASLD … Read more
Over the last 20 years, metabolic dysfunction–associated steatohepatitis (MASH) has been a partial driver of primary liver cancer (PLC), according to a review published in Clinical Gastroenterology and Hepatology.1 The investigators believe their decades-spanning analysis underscores the need to address access barriers to anti-obesity therapeutics | image credit: BillionsPhotos.com – stock.adobe.com Although MASH remains one … Read more